APA (7th ed.) Citation

Dürschmied, D., & Katus, H. (2018). Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: Should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials? Clinical research in cardiology, 107(7), . https://doi.org/10.1007/s00392-018-1242-2

Chicago Style (17th ed.) Citation

Dürschmied, Daniel, and Hugo Katus. "Antithrombotic Therapy in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Should We Change Our Practice After the PIONEER AF-PCI and RE-DUAL PCI Trials?" Clinical Research in Cardiology 107, no. 7 (2018). https://doi.org/10.1007/s00392-018-1242-2.

MLA (9th ed.) Citation

Dürschmied, Daniel, and Hugo Katus. "Antithrombotic Therapy in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Should We Change Our Practice After the PIONEER AF-PCI and RE-DUAL PCI Trials?" Clinical Research in Cardiology, vol. 107, no. 7, 2018, https://doi.org/10.1007/s00392-018-1242-2.